BATS:ARKG ARK Genomic Revolution ETF (ARKG) Price, Holdings, & News → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free ARKG Stock Alerts $23.01 -0.66 (-2.79%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$22.62▼$23.3050-Day Range$23.32▼$32.9752-Week Range N/AVolume3.16 million shsAverage VolumeN/AMarket Capitalization$1.27 billionAssets Under Management$1.30 billionDividend YieldN/ANet Expense Ratio0.75% Stock AnalysisStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Get ARK Genomic Revolution ETF alerts: Email Address About ARK Genomic Revolution ETF (BATS:ARKG)The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.Read More ARKG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ARKG ETF News HeadlinesApril 23, 2024 | finance.yahoo.comCathie Wood: Macro Environment Will Dictate Launch TimingApril 22, 2024 | fool.com3 Cathie Wood ETFs Just Hit 4-Month Lows. Are They Worth Buying Now?April 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. April 19, 2024 | americanbankingnews.comARK Genomic Revolution ETF Sees Unusually High Options Volume (BATS:ARKG)April 17, 2024 | msn.comStandard BioTools (LAB) Price Target Decreased by 10.42% to 3.65April 14, 2024 | nasdaq.comARK Genomic Revolution (ARKG) Enters Oversold TerritoryMarch 26, 2024 | markets.businessinsider.comCathie Wood's Ark Takes Profits In Rallying Crypto Stocks, Trims Nvidia And This COVID-19 Play FurtherMarch 25, 2024 | fool.comCathie Wood Is Selling This High-Yield Dividend Stock. Should You?April 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. March 19, 2024 | investorplace.com3 Biotech ETFs Overdue for a BounceSee More Headlines Receive ARKG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ARK Genomic Revolution ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerARK Fund NameARK Genomic Revolution ETF Tax ClassificationRegulated Investment Company Stock ExchangeBATSCurrent SymbolBATS:ARKG Inception Date10/31/2014 Fund ManagerCatherine Wood WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings43 Fund Statistics Assets Under Management$1.30 billion Average Daily Volume$2.44 million Discount/Premium0.01% Administrator, Advisor and Custodian AdministratorThe Bank of NewYork Mellon Corporation AdvisorARK Investment Management LLC CustodianThe Bank of NewYork Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of NewYork Mellon Corporation TrusteeN/A Lead Market MakerJane Street Options OptionableOptionable Options Volume11,670 Put Options7,555 Call Options4,115 Miscellaneous Outstanding Shares55,200,000Beta1.94 Creation Unit50,000 Creation Fee$500.00 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. ARK Genomic Revolution ETF ExpensesTypeARKGTheme ETFsEquity ETFsBATS ETFsAll ETFsManagement Fee0.75%0.57%0.54%0.56%0.51%Other Expenses0.00%0.72%0.54%0.51%0.58%Total Expense0.75%0.72%0.70%0.68%0.70%Fee Waiver0.00%-0.76%-0.55%-0.34%-0.57%Net Expense0.75%0.59%0.60%0.63%0.58% ARK Genomic Revolution ETF (ARKG) Holdings & ExposureTop 10 ARKG HoldingsCRISPR Therapeutics(NASDAQ:CRSP)Holding Weight: 7.24%Twist Bioscience(NASDAQ:TWST)Holding Weight: 5.98%Exact Sciences(NASDAQ:EXAS)Holding Weight: 5.71%Recursion Pharmaceuticals(NASDAQ:RXRX)Holding Weight: 5.29%Schrödinger(NASDAQ:SDGR)Holding Weight: 4.56%Intellia Therapeutics(NASDAQ:NTLA)Holding Weight: 4.01%Ionis Pharmaceuticals(NASDAQ:IONS)Holding Weight: 4.00%10x Genomics(NASDAQ:TXG)Holding Weight: 3.92%Beam Therapeutics(NASDAQ:BEAM)Holding Weight: 3.82%Arcturus Therapeutics(NASDAQ:ARCT)Holding Weight: 3.67%ARKG Sector ExposureARKG Industry ExposureFull Holdings Details Similar ETFsROBO Global Robotics & Automation ETFNYSEARCA:ROBOBlackRock U.S. Carbon Transition Readiness ETFNYSEARCA:LCTUARK Next Generation Internation ETFNYSEARCA:ARKWSPDR S&P 500 ESG ETFNYSEARCA:EFIVX-trackers S&P 500 ESG ETFNYSEARCA:SNPEInstitutional OwnershipCambridge Investment Research Advisors Inc.Sold 8,501 shares on 4/25/2024Ownership: 0.209%Oxler Private Wealth LLCSold 7,743 shares on 4/24/2024Ownership: 0.015%Strategic Blueprint LLCSold 2,586 shares on 4/23/2024Ownership: 0.034%Sweet Financial Partners LLCBought 500 shares on 4/23/2024Ownership: 0.030%Prospect Financial Services LLCBought 470 shares on 4/23/2024Ownership: 0.025%View All Institutional Transactions ARKG ETF - Frequently Asked Questions How have ARKG shares performed in 2024? ARK Genomic Revolution ETF's stock was trading at $32.81 at the beginning of the year. Since then, ARKG stock has decreased by 29.9% and is now trading at $23.01. View the best growth stocks for 2024 here. What does ARKG invest in? ARK Genomic Revolution ETF is a equity fund issued by ARK. ARKG focuses on theme investments. The fund's investments total to approximately $1.30 billion assets under management. What stocks does ARK Genomic Revolution ETF hold? ARKG invests in 43 holdings. Some of the stocks in their portfolio include CRISPR Therapeutics (CRSP), Twist Bioscience (TWST), Exact Sciences (EXAS), Recursion Pharmaceuticals (RXRX), Schrödinger (SDGR), Intellia Therapeutics (NTLA), Ionis Pharmaceuticals (IONS), 10x Genomics (TXG), Beam Therapeutics (BEAM) and Arcturus Therapeutics (ARCT). What is the management fee for ARK Genomic Revolution ETF? ARK Genomic Revolution ETF's management fee is 0.75% and has no other recorded expenses or fee waivers. The net expense ratio for ARKG is 0.75%. Who are ARK Genomic Revolution ETF's major shareholders? ARK Genomic Revolution ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include IMC Chicago LLC (0.00%), Cambridge Investment Research Advisors Inc. (0.21%), Purus Wealth Management LLC (0.13%), Raymond James Financial Services Advisors Inc. (0.15%), Brookstone Capital Management (0.12%) and Wealth Enhancement Advisory Services LLC (0.07%). How do I buy shares of ARK Genomic Revolution ETF? Shares of ARKG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (BATS:ARKG) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
